Towards a Body‑on‑a‑Chip

The Value of Multi-Organ MPS for Human-Relevant Drug Assessment

Watch our webinar to learn how single and multi-organ MPS can be incorporated into your drug discovery and development workflows and increase translation of preclinical assays.

Speaker Information:
Dr Tomasz Kostrzewski
Dr Tomasz Kostrzewski

VP -Science & Technology
CN Bio

Watch this webinar to learn:

  • What’s an MPS & how does it compare to standard approaches?
  • Latest multi-organ MPS developments and their value
  • How to design single- and multi-organ MPS experiments
  • The importance of generating liver-specific clinical endpoints in vitro

Microphysiological Systems (MPS), also known as organ-on-a-chip, generate human-relevant 3D cell culture models whose phenotypes and functions mimic individual in vivo organs. When therapeutics are added, these models can generate results that translate into clinical outcomes more reliably than standard in vitro techniques.

In the human body, however, no one tissue or organ operates in isolation. Could we achieve greater translation by interconnecting organ models? By linking gut and liver for example, can researchers better understand drug absorption and metabolism? Do reactive metabolites cause toxicity in different organs and at what doses? Do circulating immune cells promote inflammation and mediate toxicity?

Other webinars from our Autumn & Summer series

Join industry leaders in a series of webinars focused on Organ-On-Chip technology

The scars of fat

The transability of 3D NASH microtissues to model human/murine NASH

Watch webinar

The Rhythm of Life

Using Microfluidics To Mimic Blood Flow in Single- and Multi-Organ-on-a-Chip . . .

Watch webinar

A regulators viewpoint

Establishing strategies to evaluate microphysiological systems for drug . . .

Watch webinar

Visit cn-bio.com for more information & news